CLEC2D and breast cancer: For instance, Lectin-like Transcript-1 (LLT1, CLEC2D, OCIL) is a ligand on BC that interacts with NK cell receptor NKRP1A (CD161) leading to inhibition of NK cell-mediated cytolysis [115] (Figure 1A,B).